AL46901-EAP: A MULTICENTER, OPEN-LABEL EXPANDED ACCESS PROGRAM TO PROVIDE GIREDESTRANT TO PATIENTS WITH ER+, HER2- EARLY OR METASTATIC BREAST CANCER
- Title
- A MULTICENTER, OPEN-LABEL EXPANDED ACCESS PROGRAM TO PROVIDE GIREDESTRANT TO PATIENTS WITH ER+, HER2- EARLY OR METASTATIC BREAST CANCER
- Principal Investigator
- Jiang, Bei
- Phase
- NA
- Age Group
- Adult
- Applicable Disease Sites
- Breast Cancer
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Emily Hawkins, BSN
- Research Nurse
- Phone: +1 304-293-7375
- Email: eswiger1@hsc.wvu.edu